Overview

QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant

Status:
Completed
Trial end date:
2019-01-08
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function with kidney allografts from donors >45 years after brain death (DBD).
Phase:
Phase 3
Details
Lead Sponsor:
Quark Pharmaceuticals